Investments Australian Stock Market Falls similispharma@gmail.comJuly 15, 20260 InvestmentsBy Arjun MehtaJuly 15, 20267 min read Key Takeaways Investors dump semiconductor stocks Nasdaq declines significantly Intel shares plummet 4.5%…
Investments Stock Market Today Mixed similispharma@gmail.comJuly 14, 20260 InvestmentsBy Arjun MehtaJuly 14, 20268 min read Key Takeaways Inflation slows with a 3.2% annual increase Fed relief grows with…
Entrepreneurship US Stocks Rise Today similispharma@gmail.comJuly 12, 20260 EntrepreneurshipBy Priya SharmaJuly 12, 20268 min read Key Takeaways Dow rises to cap a choppy week Nasdaq surges with SK…
Business News HSBC Dividend Stock Soars similispharma@gmail.comJuly 11, 20260 Business NewsBy Rohan DesaiJuly 11, 20269 min read Key Takeaways HSBC surges 25% in the past quarter Dividends increase by…
Stock Market Trump Sparks Refinery Stock Surge similispharma@gmail.comJuly 10, 20260 Stock MarketBy Arjun MehtaJuly 10, 20268 min read Key Takeaways Refinery stocks surge 8% after Trump's ceasefire comment Investors flock…
Investments Stock Market Rises Amid AI Focus similispharma@gmail.comJuly 9, 20260 InvestmentsBy Arjun MehtaJuly 9, 202610 min read Key Takeaways Investors flock to tech stocks Nasdaq surges 3.3% in a week…
Startups Nasdaq Falls Amid US Iran Tensions similispharma@gmail.comJuly 8, 20260 StartupsBy Arjun MehtaJuly 8, 202610 min read Key Takeaways Dow plummets 300 points Nasdaq pares losses slowly Oil surges 3.2%…
Investments Nvidia Valuation Hits Low similispharma@gmail.comJuly 8, 20260 InvestmentsBy Arjun MehtaJuly 8, 20267 min read Key Takeaways Valuations plummet 45% for Nvidia Revenues surge 52% over the past…
Stock Market India Stock Market Surges similispharma@gmail.comJune 30, 20260 Stock MarketBy Rohan DesaiJune 30, 20268 min read Key Takeaways Markets surge with BSE Sensex gaining 2.5% in a record-breaking…
Business News Regency Centers Stock Lags S&P 500 similispharma@gmail.comJune 23, 20260 Business NewsBy Arjun MehtaJune 23, 20267 min read Key Takeaways Analysts scrutinize Regency Centers' underperformance Investors question REIT's valuation Regency…